Management of Women With Breast Cancer and Pathogenic Variants in Genes Other Than BRCA1 or BRCA2

被引：10

作者：

Robson, Mark ^{[1
]}

机构：

[1] Mem Sloan Kettering Canc Ctr, Dept Med, Breast Canc Med & Clin Genet Serv, 1275 York Ave, New York, NY 10065 USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 23期

关键词：

FAMILY-HISTORY; GERMLINE MUTATIONS; OVARIAN-CANCER; RISK; CHEK2-ASTERISK-1100DELC; SUSCEPTIBILITY; ASSOCIATION; PANEL;

D O I：

10.1200/JCO.21.00999

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The Oncology Grand Rounds series is designed to place original reports published in the Journal into clinical context. A case presentation is followed by a description of diagnostic and management challenges, a review of the relevant literature, and a summary of the authors' suggested management approaches. The goal of this series is to help readers better understand how to apply the results of key studies, including those published in the Journal of Clinical Oncology, to patients seen in their own clinical practice.

引用

页码：2528 / +

页数：8

共 50 条

[21] Genetic predisposition for breast cancer: BRCA1 and BRCA2 genes
Narod, Steven A.
Rodriguez, Adriana A.
[J]. SALUD PUBLICA DE MEXICO, 2011, 53 (05): : 420 - 429
[22] BRCA1 and BRCA2 pathogenic variants spectrum in patients with hereditary breast and ovarian cancer syndrome
Sukys, M.
Asmoniene, V.
Cereskevicius, D.
Nasvytiene, I.
Valanciute, I.
[J]. EUROPEAN JOURNAL OF HUMAN GENETICS, 2020, 28 (SUPPL 1) : 939 - 939
[23] Risk of cancer other than breast or ovarian in individuals with BRCA1 and BRCA2 mutations
Moran, A.
O'Hara, C.
Khan, S.
Shack, L.
Woodward, E.
Maher, E. R.
Lalloo, F.
Evans, D. G. R.
[J]. FAMILIAL CANCER, 2012, 11 (02) : 235 - 242
[24] BRCA1 and BRCA2 pathogenic sequence variants in women of African origin or ancestry
Friebel, Tara M.
Andrulis, Irene L.
Balmana, Judith
Blanco, Amie M.
Couch, Fergus J.
Daly, Mary B.
Domchek, Susan M.
Easton, Douglas F.
Foulkes, William D.
Ganz, Patricia A.
Garber, Judy
Glendon, Gord
Greene, Mark H.
Hulick, Peter J.
Isaacs, Claudine
Jankowitz, Rachel C.
Karlan, Beth Y.
Kirk, Judy
Kwong, Ava
Lee, Annette
Lesueur, Fabienne
Lu, Karen H.
Nathanson, Katherine L.
Neuhausen, Susan L.
Offit, Kenneth
Palmero, Edenir I.
Sharma, Priyanka
Tischkowitz, Marc
Toland, Amanda E.
Tung, Nadine
van Rensburg, Elizabeth J.
Vega, Ana
Weitzel, Jeffrey N.
Hoskins, Kent F.
Maga, Tara
Parsons, Michael T.
McGuffog, Lesley
Antoniou, Antonis C.
Chenevix-Trench, Georgia
Huo, Dezheng
Olopade, Olufunmilayo I.
Rebbeck, Timothy R.
[J]. HUMAN MUTATION, 2019, 40 (10) : 1781 - 1796
[25] Probing the relevance of BRCA1 and BRCA2 germline pathogenic variants beyond breast and ovarian cancer
Foulkes, William D.
Polak, Paz
[J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2024,
[26] Double heterozygosity for BRCA1 and BRCA2 pathogenic variants in a French metastatic breast cancer patient
Curtit, E.
Meynard, G.
Villanueva, C.
Mansi, L.
Chaix, M.
Vilalta, A.
Kuo, J. Z.
Villa, M.
Neidich, J.
Tomar, A.
Arianpour, A.
Lebahar, P.
Pivot, X.
[J]. CANCER RESEARCH, 2016, 76
[27] Risk of cancer other than breast or ovarian in individuals with BRCA1 and BRCA2 mutations
A. Moran
C. O’Hara
S. Khan
L. Shack
E. Woodward
E. R. Maher
F. Lalloo
D. G. R. Evans
[J]. Familial Cancer, 2012, 11 : 235 - 242
[28] Genes beyond BRCA1 and BRCA2 for hereditary breast cancer
Simon, Katharina
Geigl, Jochen B.
Pristauz, Gunda
[J]. WIENER MEDIZINISCHE WOCHENSCHRIFT, 2010, 160 (19-20) : 478 - 482
[29] A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes
A C Antoniou
P D P Pharoah
G McMullan
N E Day
M R Stratton
J Peto
B J Ponder
D F Easton
[J]. British Journal of Cancer, 2002, 86 : 76 - 83
[30] A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes
Antoniou, AC
Pharoah, PDP
McMullan, G
Day, NE
Stratton, MR
Peto, J
Ponder, BJ
Easton, DF
[J]. BRITISH JOURNAL OF CANCER, 2002, 86 (01) : 76 - 83

← 1 2 3 4 5 →